**Question:** Which of the following is not true about non-randomized trial?

A. Non-randomized trials involve comparing treatments between different groups of patients.
B. Non-randomized trials do not eliminate bias due to confounding factors.
C. Non-randomized trials are considered to be of lower quality than randomized controlled trials.
D. Non-randomized trials are useful in generating hypotheses and exploring new treatments.

**Core Concept:** Non-randomized trials, also known as observational studies, involve comparing treatments between different groups of patients. They are typically used to explore associations between exposures (e.g., medications, lifestyle factors) and outcomes (e.g., disease progression, patient survival). These studies are considered to be of lower quality than randomized controlled trials (RCTs) because they are more prone to confounding factors, selection bias, and other types of bias that could alter the study results. However, non-randomized trials are still valuable in generating hypotheses, refining research questions, and exploring new treatments before conducting more rigorous studies such as RCTs.

**Why the Correct Answer is Right:** The correct answer (C) highlights the main limitation of non-randomized trials compared to RCTs. Randomized controlled trials are considered superior in minimizing biases and ensuring internal validity, while non-randomized trials are more prone to confounding factors and selection bias. These biases can lead to inaccurate conclusions and unreliable results.

**Why Each Wrong Option is Incorrect:**

A. This option is incorrect because non-randomized trials do involve comparing treatments between different groups of patients, making it a crucial aspect of the study design.

B. This statement is incorrect because non-randomized trials do not eliminate bias due to confounding factors, which could significantly impact the study outcomes.

D. This statement is incorrect because non-randomized trials can contribute to hypothesis generation and preliminary exploration of new treatments before more rigorous studies, such as RCTs.

**Clinical Pearl:** When evaluating non-randomized trials, it is essential to consider the potential biases involved, including confounding factors and selection bias. These biases can influence the study results and limit the generalizability of findings. In contrast, randomized controlled trials aim to minimize these biases, providing more reliable evidence for clinical decision-making. Non-randomized trials can still be valuable for generating hypotheses and exploring new treatments, but it is crucial to acknowledge their limitations and potential biases.